These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20585759)

  • 1. Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion.
    Pehrson AL; Moghaddam B
    Psychopharmacology (Berl); 2010 Sep; 211(4):443-55. PubMed ID: 20585759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell.
    Karasawa J; Yoshimizu T; Chaki S
    Neurosci Lett; 2006 Jan; 393(2-3):127-30. PubMed ID: 16233956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.
    Ago Y; Araki R; Yano K; Hiramatsu N; Kawasaki T; Chaki S; Nakazato A; Onoe H; Hashimoto H; Baba A; Takuma K; Matsuda T
    Psychopharmacology (Berl); 2011 Oct; 217(3):443-52. PubMed ID: 21487651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex.
    Swanson CJ; Perry KW; Schoepp DD
    J Neurochem; 2004 Jan; 88(1):194-202. PubMed ID: 14675163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.
    Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Hutson PH
    Psychopharmacology (Berl); 2009 Nov; 206(4):641-51. PubMed ID: 19707745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment.
    Giorgetti M; Hotsenpiller G; Froestl W; Wolf ME
    Neuroscience; 2002; 109(3):585-95. PubMed ID: 11823068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses.
    Robbe D; Alonso G; Chaumont S; Bockaert J; Manzoni OJ
    J Neurosci; 2002 Jun; 22(11):4346-56. PubMed ID: 12040040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.
    Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S
    Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.
    Schlumberger C; Pietraszek M; Gravius A; Klein KU; Greco S; Morè L; Danysz W
    Eur J Pharmacol; 2009 Nov; 623(1-3):73-83. PubMed ID: 19765575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA receptor mediates mGlu 2/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell.
    Karasawa J; Kotani M; Kambe D; Chaki S
    Neurochem Int; 2010 Nov; 57(5):615-9. PubMed ID: 20674641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
    Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
    J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: an in vivo microdialysis study.
    Mao L; Lau YS; Wang JQ
    Eur J Pharmacol; 2000 Sep; 404(3):289-97. PubMed ID: 10996594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Schilström B; Svensson TH
    J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
    Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
    Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex.
    Jackson ME; Moghaddam B
    J Neurosci; 2001 Jan; 21(2):676-81. PubMed ID: 11160446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
    Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
    Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.